Skip to main content
. 2017 Dec 23;9(9):8290–8302. doi: 10.18632/oncotarget.23662

Figure 2. Expression level of PRDX1 is associated with poor prognosis of osteosarcoma patients.

Figure 2

(A and B) Representative images of PRDX1 IHC staining in osteosarcoma tissues. Expression level was scored base on IHC staining. Osteosarcoma patients dichotomized into low PRDX1 expression group (Score < 3; A) and high PRDX1 expression group (Score≥ 3; B). (C and D) Kaplan-Meier survival curves show that disease-free survival (DFS; left column) and overall survival (OS; right column) in training cohort. Log-rank test showed that osteosarcoma patients with high level of PRDX1 had significantly shorter DFS and OS than those with low level of PRDX1.